MyFinsight
Home
Blog
About
Acquired in-process
research and development...
$12,043M
(19324.19%↑ Y/Y)
Proceeds from debt
financing, net of issuance...
$4,085M
In-process research and
development impairments
$1,750M
(821.05%↑ Y/Y)
Amortization expense
$600M
(0.33%↑ Y/Y)
Accrued and other
liabilities
$338M
(303.61%↑ Y/Y)
Other, net
-$240M
(-627.27%↓ Y/Y)
Stock-based compensation
expense
$231M
(2.67%↑ Y/Y)
Income tax assets and
liabilities, net
$171M
(113.15%↑ Y/Y)
Depreciation expense
$98M
(5.38%↑ Y/Y)
Accounts payable
$18M
(111.11%↑ Y/Y)
Proceeds from issuances
of common stock
$9M
(-66.67%↓ Y/Y)
Net cash provided by
operating activities
$3,573M
(332.04%↑ Y/Y)
Net cash used in
financing activities
$2,344M
(249.59%↑ Y/Y)
Canceled cashflow
$11,917M
Canceled cashflow
$1,751M
Net change in cash
and cash...
-$4,450M
(-59.90%↓ Y/Y)
Canceled cashflow
$5,917M
Proceeds from sales of
marketable debt securities
$1,024M
(247.12%↑ Y/Y)
Other investing
activities, net
-$20M
(-100.00%↓ Y/Y)
Proceeds from maturities
of marketable debt...
$1M
(-93.33%↓ Y/Y)
Net (loss) income
-$10,496M
Deferred income taxes
-$587M
(-229.78%↓ Y/Y)
Net (gain) loss from
equity securities
$343M
(141.55%↑ Y/Y)
Accounts receivable, net
$333M
(14.04%↑ Y/Y)
Inventories
$145M
(-17.14%↓ Y/Y)
Prepaid expenses and
other
$13M
(116.05%↑ Y/Y)
Payments of dividends
$1,029M
(3.52%↑ Y/Y)
Repurchases of common stock
under repurchase...
$355M
(-32.64%↓ Y/Y)
Other financing
activities, net
-$350M
(-446.88%↓ Y/Y)
Repayments of debt and other
obligations
$17M
(88.89%↑ Y/Y)
Net cash used in
investing activities
-$10,347M
(-388.99%↓ Y/Y)
Canceled cashflow
$1,045M
Effect of exchange rate
changes on cash and cash...
-$19M
(-126.03%↓ Y/Y)
Acquisitions, including
in-process research and...
$11,209M
(53276.19%↑ Y/Y)
Purchases of property,
plant and equipment
$140M
(30.84%↑ Y/Y)
Purchases of marketable
debt securities
$26M
(-98.86%↓ Y/Y)
Purchases of equity
securities
$16M
(-23.81%↓ Y/Y)
Back
Back
Cash Flow
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)
source: myfinsight.com